Summary & Overview
HCPCS Q0112: Potassium Hydroxide Preparations
HCPCS Level II code Q0112 designates all potassium hydroxide (KOH) preparations used as diagnostic adjuncts in clinical settings. KOH preparations are integral to microscopic evaluation for fungal elements in skin, hair, and nail specimens, making this code relevant across dermatology, primary care, and laboratory services. Nationally, the code matters because it standardizes billing for a common, low-cost diagnostic supply that supports accurate point-of-care and laboratory diagnosis.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what Q0112 represents, the typical clinical contexts and sites of service where KOH preparations are used, and which major payers cover the service. The publication also outlines expected benchmark metrics and policy considerations where available and highlights data limitations when input data is missing.
This summary is intended for clinicians, billing professionals, and policy analysts seeking a practical understanding of the code’s clinical role, payer coverage landscape, and the types of operational and reimbursement questions that commonly arise around billing for diagnostic preparations like KOH.
Billing Code Overview
HCPCS Level II code Q0112 covers all potassium hydroxide (KOH) preparations used in clinical diagnostic testing. This code represents the supply or preparation of KOH solutions commonly used in dermatology and pathology to aid in microscopic examination of skin, hair, or nail specimens for fungal elements and other diagnostic purposes.
Service Type: Diagnostic preparation / laboratory adjunct
Typical Site of Service: Clinic, dermatology office, outpatient laboratory, or pathology lab
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient presents to an outpatient dermatology clinic with a suspicious cutaneous lesion characterized by scaling, crusting, erythema, or papulovesicular features where a fungal, yeast, or certain dermatologic infectious etiology is considered. The clinician performs a focused skin examination, documents lesion location, size, duration, and pertinent history (recent travel, immunosuppression, contact exposures). A specimen (skin scraping, scale, or nail clippings) is obtained from the lesion using a blade or curette and placed on a glass slide. In the procedure room or clinic laboratory, the clinician or trained staff applies a potassium hydroxide (KOH) preparation to the specimen and gently heats or covers with a coverslip to clear keratin. Microscopy is performed at the point of care to identify fungal hyphae, pseudohyphae, budding yeast, or dermatophyte elements. Findings are documented in the medical record, including the test type (KOH preparation), specimen source, microscopy results, clinical interpretation, and any immediate treatment decisions (topical antifungal, systemic therapy, or further diagnostic testing) or referrals. Typical sites of service are outpatient dermatology offices, primary care clinics, urgent care centers, and community health clinics. Typical patient scenarios include tinea corporis or tinea pedis evaluation, suspected candidal intertrigo, or onychomycosis assessment when a rapid in-office diagnostic test is indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|